**Specifications Table**TableSubject areaChemistry, lipids and biologyMore specific subject areaTargeted nanomedicineType of dataTable and figureHow data was acquiredParticle size, polydispersity index and surface charge (Zetasizer, NanoZS, Malvern)Data formatRaw and analyzedExperimental factorsFormulation and process parameters were changed for optimization of size and zeta potential of nanoparticles.Experimental featuresVarious formulations were prepared by single emulsification- solvent evaporation method to get nanoparticles of desired size and zeta potential.Data source locationNAData accessibilityThe data are presented in this article

**Value of data**•The article describes the preparation, optimization and characterization of solid lipid nanoparticles.•The data can be useful for other researchers investigating the effects of different lipids and surfactants on size and surface charge of nanoparticles.•The optimized formulation parameters could be used for the development of solid lipid nanoparticles of hydrophobic drugs.

1. Experimental design, material and methods {#s0005}
============================================

Solid lipid nanoparticles (SLN) i.e. lipid nanoparticles with solid matrix is the most fascinating carrier for oral drug delivery because of their excellent biocompatibility, high drug loading, long-term stability and feasibility for large scale production [@bib1], [@bib2], [@bib3], [@bib4], [@bib5]. In this study, solid lipid nanoparticles (SLN) were prepared by a single emulsification-solvent evaporation method. [Fig. 1](#f0005){ref-type="fig"} presents the various steps of preparation of SLN. Various formulation parameters ([Table 1](#t0005){ref-type="table"}) and process variables ([Table 2](#t0010){ref-type="table"}) were optimized on the basis of their effect on particle size, polydispersity index and zeta potential. These parameters included type and quantity of lipid and surfactant, quantity of co-surfactant, volume of organic phase, homogenization speed and time, sonication time, stirring speed and time. Formulations were prepared by changing one parameter at a time while keeping other parameters constant.

1.1. Optimization of formulation variables {#s0010}
------------------------------------------

### 1.1.1. Type and quantity of lipids {#s0015}

Three different lipids viz. glyceryl monostearte (GMS), tristearin and tripalmitin were used as lipid matrix. The particle diameter (PD), polydispersity index (PDI) and zeta potential (ZP) were measured using a Zetasizer NanoZS (Malvern, UK). The lipid showing minimum PD and PDI was selected and used in three different quantities (80, 100 and 120 mg).

### 1.1.2. Type and concentration of surfactants {#s0020}

The type and concentration of surfactant affect the particle size as well as stability of nanoparticles. At low concentration, surfactant will not be sufficient to cover the surface of nanoparticles resulting into increased particle size due to particle aggregation. High concentration of surfactant may lead to bridging between nanoparticles and may also cause toxicity. Therefore, three different surfactants (Tween®80, Poloxomer 188 and polyvinyl alcohol) were evaluated at three different concentrations (1%, 1.5% and 2% w/v).

### 1.1.3. Volume of organic phase {#s0025}

The organic solvent is used to dissolve the lipids and chloroform was used in this study in varying volumes (1--5 mL). The formulation showing good particle size with minimum volume of solvent was selected.

### 1.1.4. Quantity of co-surfactant {#s0030}

Lecithin soy was used as co-surfactant which act as internal emulsifier and favors to particle size reduction and stability. Lecithin soy was used at different concentration (20, 30 and 40) to get a formulation having small particle size, less PDI with good zeta potential and stability.

1.2. Optimization of process variables {#s0035}
--------------------------------------

### 1.2.1. Homogenization speed and time, sonication time and stirring speed and time {#s0040}

The organic phase was poured in aqueous surfactant phase and homogenized at different speed (5000, 8000 and 11000 rpm) for different time (3, 4, 5 and 6 min) to get course emulsion. Then this course emulsion was sonicated for different time period to get a nanoemulsion. Finally formulation was stirred to evaporate the organic solvent and to get the nanoparticles. The formulation was stirred at different speed (800, 1000, and 1200 rpm) and for different time period (1, 2 and 3 h) for optimization.

Appendix A. Supplementary material {#s0050}
==================================

Supplementary material
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![Flow chart representing the preparation of solid lipid nanoparticles.](gr1){#f0005}

###### 

Optimization of various formulation parameters for the preparation of solid lipid nanoparticles.

Table 1

  Formulation                                     Variable        PD (nm)   PDI          ZP (mV)     
  ----------------------------------------------- --------------- --------- ------------ ----------- -----------
  *Type of lipid*                                                                                    
  F1                                              GMS             100       55.53±2.4    0.23±0.04   −23.2±2.1
  F2                                              Tristearin      100       157.5±6.7    0.35±0.11   −26.9±2.3
  F3                                              Tripalmitin     100       119.5±3.9    0.43±0.08   −22.1±1.9
  *Quantity of lipid* (mg)                                                                           
  F4                                              GMS             80        49.28±3.1    0.27±0.09   −21.8±1.6
  F1                                              GMS             100       55.53±2.4    0.23±0.04   −23.2±2.1
  F6                                              GMS             120       55.09±3.7    0.30±0.02   −29.7±2.3
  *Type and concentration of surfactant* (%w/v)                                                      
  F7                                              Tween 80        1         66.67±2.5    0.36±0.12   −31.8±2.4
  F1                                              Tween 80        1.5       55.53±2.4    0.23±0.04   −23.2±2.1
  F8                                              Tween 80        2         133.2±5.6    0.27±0.08   −26.6±1.8
  F9                                              Poloxomer 188   1         61.4±4.4     0.38±0.09   −29.9±2.3
  F10                                             Poloxomer 188   1.5       65.7±3.9     0.40±0.12   −26.4±2.1
  F11                                             Poloxomer 188   2         64.9±2.8     0.39±0.10   −23.5±2.5
  F12                                             PVA             1         120.92±6.1   0.15±0.09   −32.0±1.9
  F13                                             PVA             1.5       108.84±4.3   0.20±0.07   −26.6±2.4
  F14                                             PVA             2         102.86±4.8   0.21±0.11   −24.5±1.8
  *Volume of organic solvent* (mL)                                                                   
  F15                                             CHCl~3~         1         48.91±2.4    0.36±0.11   −19.6±1.4
  F16                                             CHCl~3~         2         52.81±1.9    0.21±0.07   −24.3±2.6
  F1                                              CHCl~3~         3         55.53±2.4    0.23±0.04   −23.2±2.1
  F17                                             CHCl~3~         5         47.73±2.6    0.25±0.04   −23.7±2.3
  *Quantity of co-surfactant (mg)*                                                                   
  F16                                             lecithin soy    20        52.81±1.9    0.21±0.07   −24.3±2.6
  F18                                             lecithin soy    30        47.54±2.3    0.21±0.09   −25.5±1.8
  F19                                             lecithin soy    40        50.32±3.1    0.28±0.10   −28.6±2.4

GMS: Glyceryl monostearte; PVA: Polyvinyl alcohol; PD: Particle diameter, PDI: Polydispersity index; ZP: Zeta potential.

###### 

Optimization of various process variables for preparation solid lipid nanoparticles.

Table 2

  Formulation                    Variable   PD (nm)      PDI         ZP (mV)
  ------------------------------ ---------- ------------ ----------- -----------
  *Homogenization speed* (rpm)                                       
  F20                            5000       64.67±4.8    0.56±0.03   −27.5±2.5
  F18                            8000       47.54±2.3    0.21±0.09   −25.5±1.8
  21                             11000      44.43±3.1    0.26±0.03   −26.5±2.1
  *Homogenization time* (min)                                        
  F22                            3          157.92±5.7   0.45±0.05   −30.3±3.1
  F23                            4          76.21±3.9    0.28±0.07   −25.8±2.8
  F21                            5          44.43±3.1    0.26±0.03   −26.5±2.1
  F24                            6          71.23±4.8    0.29±0.11   −23.9±2.7
  *Sonication time* (min)                                            
  F25                            5          \>500        --          --
  F26                            10         135.45±6.7   0.32±0.13   −27.1±2.9
  F21                            15         44.43±3.1    0.26±0.03   −26.5±2.1
  F27                            20         49.89±2.8    0.24±0.09   −25.8±2.6
  *Stirring speed* (rpm)                                             
  F28                            800        59.02±3.9    0.25±0.05   −20.1±1.9
  F21                            1000       44.43±3.1    0.26±0.03   −26.5±2.1
  F29                            1200       67.82±4.2    0.27±0.02   −22.9±2.5
  *Stirring time* (h)                                                
  F30                            1          69.48±4.5    0.42±0.07   −28.4±2.7
  F31                            2          57.37±5.1    0.31±0.05   −26.4±1.8
  F21                            3          44.43±3.1    0.26±0.03   −26.5±2.1
  F32                            4          61.34±3.8    0.25±0.09   −26.2±2.5
